# Comorbidity Ensemble ML Implementation Progress

Tracking implementation and validation of the 20-phase ML architecture specified in `COMORBIDITY_ENSEMBLE_ML_PLAN.md`.

---

## Phase Status Summary

- [x] **Phase 1 — Dataset / Schema Inspection**: [COMPLETED & AUDITED]
- [x] **Phase 2 — Patient Timeline Construction**: [COMPLETED & AUDITED]
- [x] **Phase 3 — Landmark & Label Generation**: [COMPLETED & VALIDATED]
- [x] **Phase 4 — Feature Engineering & Target Dissection EDA**: [COMPLETED & VERIFIED]
- [x] **Phase 5 — Train / Validation / Test Splitting**: [COMPLETED & AUDITED]
- [x] **Phase 6 — Baseline Models & Metric Harness**: [COMPLETED & VERIFIED]
- [x] **Phase 7 — Logistic Regression Base Model**: [COMPLETED & AUDITED]
- [x] **Phase 8 — Random Forest Base Model**: [COMPLETED & AUDITED]
- [x] **Phase 9 — XGBoost Base Model**: [COMPLETED & AUDITED]
- [ ] **Phase 10 — Proper Stacked Ensemble (OOF)**: [NOT STARTED]
- [ ] **Phase 11 — Hyperparameter Tuning Finalization**: [NOT STARTED]
- [ ] **Phase 12 — Calibration**: [NOT STARTED]
- [ ] **Phase 13 — Explainability**: [NOT STARTED]
- [ ] **Phase 14 — Evaluation**: [NOT STARTED]
- [ ] **Phase 15 — Ablation Experiments**: [NOT STARTED]
- [ ] **Phase 16 — Model Packaging**: [NOT STARTED]
- [ ] **Phase 17 — Inference Pipeline**: [NOT STARTED]
- [ ] **Phase 18 — Streamlit Integration**: [NOT STARTED]
- [ ] **Phase 19 — Testing & Leakage Audits**: [NOT STARTED]
- [ ] **Phase 20 — Final Experiment & Reproducibility Pass**: [NOT STARTED]

---

## Phase 9 Execution & Validation Log

### 1. What was Implemented & Validated
- **XGBoost Architecture & Early Stopping Module (`src/models/xgboost_model.py`)**:
  - Configurable `build_xgb_classifier` with automatic CUDA GPU device detection (`device='cuda'`, `tree_method='hist'`) and CPU fallback.
  - Class weighting: `scale_pos_weight = N_neg / N_pos` capped at 500.0 for numerical stability on rare targets.
  - Hyperparameter grid search across tree depth (`max_depth \in [4, 6, 8]`), learning rate (`0.03, 0.05`), and L2 regularization (`reg_lambda \in [1.0, 5.0]`).
  - **Early Stopping**: Strictly wired to validation split (`early_stopping_rounds=15`) on validation logloss to prevent overfitting.
  - Multi-type feature importance extraction (Gain, Weight, Cover) for all 81 active clinical predictors.
  - Full learning curve extraction recording train vs validation logloss per boosting iteration.
- **Execution & Deliverables (`scripts/train_xgboost.py`)**:
  - All 41 models trained and saved to `models/saved/xgb_tuned/model_<cid>.joblib` + metadata JSONs.
  - Multi-target evaluation executed across Validation and Prospective Test splits.
  - Generated reports:
    - `reports/phase9_xgb_evaluation.md` & `reports/phase9_xgb_evaluation.json`
    - `reports/phase9_xgb_learning_curves.md` & `reports/phase9_xgb_learning_curves.json`
    - `reports/phase9_xgb_feature_importances.md` & `reports/phase9_xgb_feature_importances.json`
  - Headline Results:
    - **Validation Macro-AUPRC**: **0.1040** | **Validation Macro-AUROC**: **0.8851**
    - **Test Macro-AUPRC**: **0.0816** (**32.6x lift** over prevalence baseline floor, **+10.4%** over Random Forest, **+62.5%** over Logistic Regression) | **Test Macro-AUROC**: **0.8824**
    - **Test Precision@3**: **26.95%** | **Test Recall@3**: **66.65%** | **Test MAP@3**: **0.5555**

---

### 2. Automated Test Suite (Phase 1–9)
- Ran `pytest -v tests/`
- **40/40 tests PASSED** (100% pass rate in 8.05s).
- Added `test_multitarget_evaluation_signature_regression` preventing API keyword mismatches (`Y_pred_proba`).

---

### 3. Git Commits & Push Log
- Code, scripts, reports, and tests staged and committed.
- Pushed to `https://github.com/PrathamTandon1507/Healthcare.git` (`origin/main`).
